Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | NPY4R | P50391 | 13/20 | 0.49 |
| ▸ | NPY1R | P25929 | 9/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.49 |
| ▸ | NPY2R | P49146 | 5/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17364037 | 1.00 | SMN1; SMN2 (0.64) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL26807763 | 0.96 | SMN1; SMN2 (0.69) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL17364033 | 0.96 | SMN1; SMN2 (0.69) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL5966873 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL3280675 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL23132673 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL642095 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL18328611 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| Antipain SCHEMBL14038024 | 0.93 | SMN1; SMN2 (0.74) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29434599 | 0.88 | CASP3 (0.54) | SMN1; SMN2NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566239-B2 | Stabilized cellulase variants | NOVOZYMES A/S (DK) | 2023-01-31 | — | — | US | disclosed |
| US-20220186151-A1 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | NOVOZYMES A/S (DK) | 2022-06-16 | — | — | US | disclosed |
| US-20210363510-A1 | STABILIZED CELLULASE VARIANTS | NOVOZYMES A/S (DK) | 2021-11-25 | — | — | US | disclosed |
| US-20150376554-A1 | Industrial and Institutional Laundering Using Multi-Enzyme Compositions | NOVOZYMES AS (DK) | 2015-12-31 | — | — | US | disclosed |